Quintanal-Villalonga, Á., Ferrer, I., Guruceaga, E., Cirauqui, C., Marrugal, Á., Ojeda, L., . . . Paz-Ares, L. (2023). FGFR1 and FGFR4 oncogenicity depends on n-cadherin and their coexpression may predict FGFR-targeted therapy efficacy.
Chicago Style (17th ed.) CitationQuintanal-Villalonga, Á, et al. FGFR1 and FGFR4 Oncogenicity Depends on N-cadherin and Their Coexpression May Predict FGFR-targeted Therapy Efficacy. 2023.
MLA (8th ed.) CitationQuintanal-Villalonga, Á, et al. FGFR1 and FGFR4 Oncogenicity Depends on N-cadherin and Their Coexpression May Predict FGFR-targeted Therapy Efficacy. 2023.
Warning: These citations may not always be 100% accurate.